The-challenges-to-adopting-R-for-clinical-submissions
We spoke to experts at Janssen, Roche, Bayer and other world-leading pharmaceutical organisations about their experiences using R in a clinical setting and discussed how tackling the challenges of accessing open-source analytics tools for clinical submissions should be a priority.